IP Verse

Amgen Inc. V. Msn Laboratories Private Limited - 1:23-cv-00031

Amgen Inc. V. Msn Laboratories Private Limited (Case No. 1:23-cv-00031), filed on Jan 12, 2023 in the District Court, D. Delaware involving patent infringement. This case involves patent infringement claims between the parties. Explore details about the litigants, key filings, and major docket updates.

Case Details

Case Number
1:23-cv-00031
Filing Date
Jan 12, 2023
Cause of Action
Patent Infringement
Status
-
Court
District Court, D. Delaware
Nature of Suit
Patent - Abbreviated New Drug Application(ANDA)

Parties Involved

The following parties are involved in this case, with their respective legal representatives for the case.

NameRepresented By
Amgen Inc. -
MSN Life Sciences Private Limited -
KAI Pharmaceuticals, Inc. -

Patents Involved

There is a single patent involved in this case.

Application NumberPatent Number
-US11162500B2

Docket Entries

The Docket Entries section provides a chronological list of all significant filings and court actions in this case.

DateDocket EntryType

Set alerts for critical docket entry

Jan 12, 2023Summons Issued as to MSN Laboratories Private Limited, MSN Life Sciences Private Limited, MSN Pharmaceuticals Inc. on 1/12/2023. (Attachments: # 1 Summons Issued, # 2 Summons Issued)(twk) (Entered: 01/12/2023)PACER Document
Jan 12, 2023Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Amgen Inc. for KAI Pharmaceuticals, Inc. filed by Amgen Inc., KAI Pharmaceuticals, Inc. (twk) (Entered: 01/12/2023)PACER Document
Jan 12, 2023Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 11,162,500. (twk) (Entered: 01/12/2023)PACER Document
Jan 12, 2023Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: November 30, 2022. Date of Expiration of Patent: June 27, 2034. Thirty Month Stay Deadline: 8/7/2024. (twk) (Entered: 01/12/2023)PACER Document
Jan 12, 2023Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (twk) (Entered: 01/12/2023)PACER Document
Jan 12, 2023COMPLAINT filed against MSN Laboratories Private Limited, MSN Life Sciences Private Limited, MSN Pharmaceuticals Inc. ( Filing fee $ 402, receipt number ADEDC-4042573.) - filed by Amgen Inc., KAI Pharmaceuticals, Inc. (Attachments: # 1 Exhibit A, # 2 Related Cases, # 3 Civil Cover Sheet)(twk) (Entered: 01/12/2023)PACER Document